{
  "ticker": "REGN",
  "last_updated": "2025-04-15T11:58:43.759656",
  "retention_years": 3,
  "count": 26,
  "transactions": [
    {
      "id": 20273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-05",
      "transaction_shares": "1844",
      "transaction_price": "749.0",
      "transaction_type": "S",
      "shares_after_transaction": "16425"
    },
    {
      "id": 20263,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "2",
      "transaction_price": "705.39",
      "transaction_type": "S",
      "shares_after_transaction": "19580"
    },
    {
      "id": 20264,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-10-03",
      "transaction_shares": "600",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20244"
    },
    {
      "id": 20276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2022-10-03",
      "transaction_shares": "3346",
      "transaction_price": "724.0",
      "transaction_type": "S",
      "shares_after_transaction": "18269"
    },
    {
      "id": 20280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-03",
      "transaction_shares": "279",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "279"
    },
    {
      "id": 20265,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-29",
      "transaction_shares": "3798",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "6067"
    },
    {
      "id": 20268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2022-09-09",
      "transaction_shares": "30000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "41580"
    },
    {
      "id": 20270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2022-09-09",
      "transaction_shares": "40000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "70578"
    },
    {
      "id": 20261,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-08",
      "transaction_shares": "1279",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2361"
    },
    {
      "id": 20267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "2216",
      "transaction_price": "374.12",
      "transaction_type": "M",
      "shares_after_transaction": "3309"
    },
    {
      "id": 20275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-09-06",
      "transaction_shares": "3",
      "transaction_price": "576.85",
      "transaction_type": "S",
      "shares_after_transaction": "19679"
    },
    {
      "id": 20262,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-09-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-08-15",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 20271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "15000",
      "transaction_price": "177.82",
      "transaction_type": "M",
      "shares_after_transaction": "16872"
    },
    {
      "id": 20278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-04",
      "transaction_shares": "2500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "19682"
    },
    {
      "id": 20282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 7144,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-07-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 7145,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-06-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-06-01",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 7146,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-05-16",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 20274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2022-05-16",
      "transaction_shares": "10000",
      "transaction_price": "179.13",
      "transaction_type": "M",
      "shares_after_transaction": "68470"
    },
    {
      "id": 7147,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "5",
      "transaction_price": "643.76",
      "transaction_type": "S",
      "shares_after_transaction": "22277"
    },
    {
      "id": 7148,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-05-02",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    },
    {
      "id": 20277,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "5",
      "transaction_price": "643.76",
      "transaction_type": "S",
      "shares_after_transaction": "22277"
    },
    {
      "id": 20281,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2022-05-02",
      "transaction_shares": "1100",
      "transaction_price": "342.93",
      "transaction_type": "M",
      "shares_after_transaction": "20744"
    }
  ]
}